- Home
- GENK vs IRIX Comparison
GENK vs IRIX Comparison
Compare GENK & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENK
- IRIX
- Stock Information
- Founded
- GENK 2011
- IRIX 1989
- Country
- GENK United States
- IRIX United States
- Employees
- GENK N/A
- IRIX N/A
- Industry
- GENK Restaurants
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GENK Consumer Discretionary
- IRIX Health Care
- Exchange
- GENK Nasdaq
- IRIX Nasdaq
- Market Cap
- GENK 20.4M
- IRIX 16.5M
- IPO Year
- GENK 2023
- IRIX 1996
- Fundamental
- Price
- GENK $3.36
- IRIX $1.12
- Analyst Decision
- GENK Strong Buy
- IRIX
- Analyst Count
- GENK 2
- IRIX 0
- Target Price
- GENK $7.00
- IRIX N/A
- AVG Volume (30 Days)
- GENK 96.4K
- IRIX 193.2K
- Earning Date
- GENK 08-06-2025
- IRIX 08-12-2025
- Dividend Yield
- GENK 0.88%
- IRIX N/A
- EPS Growth
- GENK N/A
- IRIX N/A
- EPS
- GENK N/A
- IRIX N/A
- Revenue
- GENK $216,137,000.00
- IRIX $49,744,000.00
- Revenue This Year
- GENK $17.79
- IRIX $9.61
- Revenue Next Year
- GENK $15.87
- IRIX N/A
- P/E Ratio
- GENK N/A
- IRIX N/A
- Revenue Growth
- GENK 10.67
- IRIX 0.09
- 52 Week Low
- GENK $3.16
- IRIX $0.78
- 52 Week High
- GENK $10.33
- IRIX $2.14
- Technical
- Relative Strength Index (RSI)
- GENK 38.39
- IRIX 44.58
- Support Level
- GENK $3.16
- IRIX $1.27
- Resistance Level
- GENK $4.16
- IRIX $1.34
- Average True Range (ATR)
- GENK 0.28
- IRIX 0.08
- MACD
- GENK -0.08
- IRIX -0.03
- Stochastic Oscillator
- GENK 22.83
- IRIX 0.00
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.